A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension
The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension...
Brief Summary
Official Title: “A Phase IIIb Study of DuoTrav to Treat Glaucoma or Ocular Hypertension”
The purpose of this study is to assess patient compliance with DuoTrav versus concomitant administration of Timolol 0.5% plus TRAVATAN in patients with open-angle glaucoma or ocular hypertension.
- Study Type: Interventional
- Study Design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment
- Study Primary Completion Date: January 2010
Intervention(s) in this Clinical Trial
- Drug: Travoprost/Timolol
Outcome Measures for this Clinical Trial
Primary Measures
- Patient compliance
Criteria for Participation in this Clinical Trial
Inclusion Criteria:
- Adult patients with open-angle glaucoma or ocular hypertension
Exclusion Criteria:
- LogMAR visual acuity worse than 0.60
Gender Eligibility for this Clinical Trial: Both
Minimum Age for this Clinical Trial: 18 Years
Maximum Age for this Clinical Trial: N/A
Are Healthy Volunteers Accepted for this Clinical Trial?: No
Clinical Trial Investigator Information
Lead Investigator: Alcon Research Industry
Overall Clinical Trial Officials and Contacts
Theresa Landry Study Director Alcon Research
Additional Information
Information obtained from ClinicalTrials.gov on February 09, 2012
Link to the current ClinicalTrials.gov record. http://clinicaltrials.gov/show/NCT00465803
Study ID Number: C-06-21
ClinicalTrials.gov Identifier: NCT00465803
Health Authority: United States: Food and Drug Administration
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is:
http://clinicaltrialsfeeds.org/clinical-trials/show/NCT00465803
